And knowing the key differences can help you when youre talking with your doctor about which might be right for you
What Does This Change in Status Mean
The groundbreaking Harvard research revealed these concerning statistics: Diabetic patients on semaglutide showed a 4.28-fold increased NAION risk (hazard ratio 4.28
Thrilled to share our latest publication comparing #cardiovascular outcomes in real-world patients with type 2 diabetes treated with semaglutide or dulaglutide vs empagliflozin - paper out now in Annals of Internal Medicine
Before using this medication, tell your doctor or pharmacist your medical history, especially of: a certain eye problem (diabetic retinopathy), a disease of the pancreas (pancreatitis), kidney problems, stomach/intestinal disorders (such as gastroparesis, digestion problems)
Mean Insulin Secretion Rate Versus Glucose Concentration in Patients with Type 2 Diabetes during Graded Glucose Infusion before (Baseline) and after 12 Weeks of Treatment with Semaglutide or Placebo and in Untreated Healthy Subjects During induced hypoglycemia, semaglutide did not alter the counter regulatory responses of increased glucagon compared to placebo and did not impair the decrease of C-peptide in patients with type 2 diabetes
